Stocks Actavis Inc

More

  • BRUSSELS, Oct 5- The following are mergers under review by the European Commission and a brief guide to the EU merger process:. --Private equity firms Carlyle and BC Partners to acquire U.S. industrial pumps maker Hamilton Sundstrand Industrial which is owned by United Technologies Corp.

  • BRUSSELS, Oct 4- The following are mergers under review by the European Commission and a brief guide to the EU merger process:. --Private equity firms Carlyle and BC Partners to acquire U.S. industrial pumps maker Hamilton Sundstrand Industrial which is owned by United Technologies Corp.

  • BRUSSELS, Oct 3- The following are mergers under review by the European Commission and a brief guide to the EU merger process:. --Private equity firms Carlyle and BC Partners to acquire U.S. industrial pumps maker Hamilton Sundstrand Industrial which is owned by United Technologies Corp.

  • Oct 3- Watson Pharmaceuticals Inc:. *RBC raises Watson Pharmaceuticals Inc price target to $98 from $88;. Reuters Station users, click. 1568.

  • WASHINGTON, Oct 2- U.S. antitrust regulators found no wrongdoing in a deal made four years ago between German drugmaker Bayer AG and a division of Teva Pharmaceuticals to end patent litigation over the popular Yasmin birth control pill.

  • Oct 1- Watson Pharmaceuticals Inc:. *Confirms favorable district court ruling in androgelï¿ ½ 1% antitrust litigation. *Says court found that the plaintiffs' claims were unsustainable.

  • BRUSSELS, Oct 1- The following are mergers under review by the European Commission and a brief guide to the EU merger process:. --Private equity firms Carlyle and BC Partners to acquire U.S. industrial pumps maker Hamilton Sundstrand Industrial which is owned by United Technologies Corp.

  • Not everyone has the kind of capital Leon Cooperman has to buy stocks. From his 10 top picks, the Fast traders reveal their single favorites.

  • market-insider-stocks-to-watch-200.jpg

    Check out which companies are making headlines after the bell Wednesday:

  • market-insider-stocks-to-watch-200.jpg

    Take a look at some of Monday’s morning movers:

  • Watson Pharmaceuticals

    Although Watson Pharmaceuticals’ acquisition of Swiss generic drug maker Actavis was expected for over a month, a strong reaction to Wednesday’s deal shows that analysts are hooked on the drugmaker.

  • market-insider-stocks-to-watch-200.jpg

    Take a look at some of Thursday's morning movers.

  • market-insider-stocks-to-watch-AB-200.jpg

    Check out which companies are making headlines after-the-bell Wednesday:

  • stock_ticker_blur_200.jpg

    Earlier in the trading session, eBay shares were up as much as 16.6 percent, their best intraday gain since Oct. 2008.

  • stock_ticker_blur_200.jpg

    Stocks in the S&P 1,500 displaying unusual volume in Thursday's trading session.

  • Stocks ended narrowly mixed in a lackluster session Wednesday following a weaker-than-expected existing home sales report and as investors were reluctant to jump in following the recent market rally.

  • Fast Money Portfolio

    Some of the steadiest growth stocks lie in pharmaceuticals and agricultural plays, one noted investor said Thursday.

  • Watson CEO on Generic Drug Market

    Generic medicines accounted for over 75% of prescriptions dispensed by retail drug stores in 2010. And today that number keeps growing. Paul Bisaro, Watson Pharmaceuticals CEO, provides industry perspective.

  • Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • market-insider-stocks-to-watch-200.jpg

    Take a look at some of Monday morning's early movers: